Five things for pharma marketers to know: Thursday, December 31, 2015


1. After a lawsuit decided in AstraZeneca's favor, Dr. Reddy's Laboratories relaunched generic Nexium with a different color pill and a different color cap. AstraZeneca had sued, saying it has trademarks for the “purple pill.” The relaunched Nexium is blue. (WSJ)

2. A psychologist recently suggested that scientific papers be anonymous, including those published in medical journals. Doing this may mean a wider range of authors are published by removing personal biases. (Stat News)

3. Patients with health insurance still struggle to cost costs when they are prescribed high priced drugs.Some patients make too much money to qualify for financial assistance from the drugmaker, while such assistance is not an option for drug companies. (WSJ)

4. The Accreditation Council for Continuing Medical Education and PharmedOut, which studies the impact of pharma marketing on prescribing, are squaring off in the pages of a medical journal over the current standards in place for CME. (MM&M)

5. ICYMI: While campaigning this week in New Hampshire, Hillary Clinton said  that the drug industry is afraid of her and said she plans to tackle rising drug prices. The presidential candidate mentioned former Turing CEO as well as why it's cheaper to get a hepatitis-C drug in Egypt that it is in the US. (Bloomberg Business)


Next Article in Commercial